
News from psychedelicalpha.com
We’ve assigned a media bias rating of unknown to psychedelicalpha.com. You can read more about our methodology here.
If you want to know if psychedelicalpha.com is credible or reliable, look no further. We rank psychedelicalpha.com as Unknown factuality. Find out more about our methodology here.
Information about psychedelicalpha.com
Where is psychedelicalpha.com located?psychedelicalpha.com's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top psychedelicalpha.com News

Consciousness · LondonAn LSD trip with a neuroscientist turned Rocky’s London sessions into one of his biggest creative experiments. [...] Read More... The post That Time A$AP Rocky Took LSD with a Psychedelic Scientist appeared first on DoubleBlind Mag.See the Story
That Time A$AP Rocky Took LSD with a Psychedelic Scientist

Kyrsten Sinema · TijuanaOn Wednesday afternoon at Psychedelic Science I (Psychedelic Alpha Editor Josh Hardman) sat down with former U.S. Senator Kyrsten Sinema for a conversation about her vocal advocacy for ibogaine. We sat at the booth of Tijuana-based ibogaine clinic Ambio Life Sciences in the bustling Expo Hall. Sinema’s style was just as eccentric as her political background, with a bright outfit and translucent… SourceRead Article
From Senate to Psychedelics: Kyrsten Sinema’s Ibogaine Advocacy Playbook - Psychedelic Alpha
Pα+ Psychedelic Bulletin #202: Psychedelics Access ‘Within 12 Months’, RFK Jr. Says; Psychedelics in Washington; Lykos’ New CEO, CMO; New Zealand’s First Psilocybin Prescriber; Judge Recommends Schedule I Placement for DOI and DOC - Psychedelic Alpha
Applications Open Soon for Psychedelic Healing Centers in Denver
Coverage: 7 sources
Compass Pathways Stock Slumps After Positive Late-Stage Trial Results ...
100% Center coverage: 5 sources
Emyria Wins Major Insurer Backing for MDMA-Assisted Therapy
100% Right coverage: 1 sources
May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate Following Positive Phase 2a Readout; Lykos Publishes Further Continuation Applications; Reconnect Joins Crowded 5-MeO-DMT Patent Landscape - Psychedelic Alpha
Texas Invests $50 Million in Ibogaine Research for Addiction Treatment, Advocates Still Eye Tri-State
72% Center coverage: 18 sources